Projects In Knowledge: Game Changers in Hepatology—Future Challenges in the Treatment of HCV

Game Changers in Hepatology—Future Challenges in the Treatment of HCV

PLEASE NOTE:

As required by the ACCME, all participants must read the information below before proceeding to this activity.

After doing so, please click the View Webcast button at the bottom of this page.

How will watching this webcast help you?

Understand how changes on the healthcare horizon, such as electronic medical records and new reimbursement structures, will affect your practice
Review the benefits and limitations of current treatment options for HCV
Learn how increasingly complex emerging therapeutic regimens fit within the new healthcare paradigm

Chair
	Ira M. Jacobson, MD Vincent Astor Professor of Medicine Chief, Division of Gastroenterology and Hepatology Medical Director of the Center for the Study of Hepatitis C Weill Cornell Medical College New York, New York
Faculty
	Nezam H. Afdhal, MD Associate Professor of Medicine Harvard Medical School Chief of Hepatology Beth Israel Deaconess Medical Center Boston, Massachusetts	Bruce R. Bacon, MD James F. King MD Endowed Chair in Gastroenterology Professor of Internal Medicine Director, Division of Gastroenterology and Hepatology Saint Louis University School of Medicine St. Louis, Missouri
Featured Speaker(s)
	Rosemarie Nelson, MS Principal MGMA Health Care Consulting Group Englewood, Colorado

Target Audience
This CME/CE activity has been designed for hepatologists, gastroenterologists, infectious disease specialists, and other clinicians involved in the care of patients with HCV.

Activity Goal
The goal of Game Changers in Hepatology – Future Challenges in the Treatment of HCV is to provide clinicians with up-to-date information on the impact that changes in the practice of medicine will have on the treatment of patients with HCV, and to discuss current and new agents for the treatment of this disease.
top

Learning Objectives

•	Assess the impact of changes in medical practice, including EMR, new reimbursement paradigms, and healthcare reform, in the practice setting and the care of patients with chronic hepatitis C.
•	Evaluate the benefits and limitations of current treatment options for the management of patients with chronic hepatitis C.
•	Assess the benefits and limitations of new treatment options, including modifications of IFN and ribavirin and inhibitors of viral protease and polymerase, in the treatment of chronic hepatitis C.

top

CME Information: Physicians
Statement of Accreditation
Projects In Knowledge^® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Projects In Knowledge designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CE Information: Nurses
Projects In Knowledge^® (PIK) is an approved provider of continuing nursing education by the Delaware Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. PIK provider code: 080903-PROV.

Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227.

This activity is approved for 1.50 nursing contact hour(s).

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, DNA, CBRN, or PIK endorsement of any commercial product or service.

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, DNA, CBRN, or PIK endorsement of any commercial product or service.

CE Information: Pharmacists

Projects In Knowledge^® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This od simultaneous webcast is worth up to 1.50 contact hours (0.15 CEUs). The ACPE Universal Program Number assigned to this application activity is 0052-0000-09-087-H01-P.
top

Disclosure Information
The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

Contract for Mutual Responsibility in CME/CE

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

	View Webcast Requires Flash 8 or higher and high-speed internet
top	1937